Go to
JCI Insight
About
Editors
Consulting Editors
For authors
Publication ethics
Publication alerts by email
Advertising
Job board
Contact
100th anniversary
Current issue
Past issues
By specialty
COVID-19
Cardiology
Gastroenterology
Immunology
Metabolism
Nephrology
Neuroscience
Oncology
Pulmonology
Vascular biology
All ...
Videos
Conversations with Giants in Medicine
Author's Takes
Reviews
Reviews
View all reviews ...
Review Series
Vascular Malformations (Upcoming)
Lung inflammatory injury and tissue repair (Jul 2023)
Immune Environment in Glioblastoma (Feb 2023)
Korsmeyer Award 25th Anniversary Collection (Jan 2023)
Aging (Jul 2022)
Next-Generation Sequencing in Medicine (Jun 2022)
New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
View all review series ...
Viewpoint
Collections
In-Press Preview
Commentaries
Research Letters
Letters to the Editor
Editorials
Viewpoint
JCI This Month
Top read articles
Clinical Medicine
Eosinophil-dependent bromination in the pathogenesis of asthma
Jay W. Heinecke
Jay W. Heinecke
Published May 15, 2000
Citation Information:
J Clin Invest.
2000;
105(10)
:1331-1332.
https://doi.org/10.1172/JCI10072
.
View:
Text
|
PDF
Commentary
Eosinophil-dependent bromination in the pathogenesis of asthma
Text
PDF
Abstract
Authors
Jay W. Heinecke
×
Figure 1
Options:
View larger image
(or click on image)
Download as PowerPoint
Proposed mechanisms for the pathogenesis of inflammation in asthma. Whereas mast cells are directly stimulated by allergen-specific IgEs and provoke the early phase of asthmatic bronchoconstriction, eosinophils activate later inflammatory responses.